Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim–Chester disease

Fig. 1

Changes in laboratory measures during treatment. a. Serum high sensitive CRP (hsCRP) levels; b Serum cytokines interleukin-6 (IL-6) levels; c Serum interleukin-8 (IL-8) levels; D. Serum tumor necrosis factor-α (TNF-α) levels. In all panels, the red lines represent patients who experienced disease progression during treatment. The blue lines represent patients who died during treatment. The gray lines represent patients who experienced continuous clinical improvement

Back to article page